Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation
CHD1 的缺失通过染色质失调促进对 AR 靶向治疗产生异质性耐药机制
期刊:Cancer Cell
影响因子:48.8
doi:10.1016/j.ccell.2020.03.001
Zeda Zhang, Chuanli Zhou, Xiaoling Li, Spencer D Barnes, Su Deng, Elizabeth Hoover, Chi-Chao Chen, Young Sun Lee, Yanxiao Zhang, Choushi Wang, Lauren A Metang, Chao Wu, Carla Rodriguez Tirado, Nickolas A Johnson, John Wongvipat, Kristina Navrazhina, Zhen Cao, Danielle Choi, Chun-Hao Huang, Eliot Lin
信号转导
ICC
ICC-IF
IHC
WB
Human
STEA1
